article thumbnail

9 Technologies That Will Shape The Future Of Dentistry

The Medical Futurist

AI in oral and maxillofacial pathology: early detection, targeted treatments Oral cancers and other serious issues can lurk undetected with biopsies being the only way to diagnose them. Researchers in 2019 developed a machine learning method to accurately quantify immune cells in the vicinity of oral cancer cells.

Patients 126
article thumbnail

Direct-to-consumer advertising distorts prescription drugs’ benefits and costs

Common Sense Family Doctor

On Sensible Medicine, Dr. Edward Livingston pointed out that the manufacturer, AbbVie, spent $580 million on DTCA for this drug in 2023, or $290 for each of the 2 million potential patients in the United States. The annual price of risankizumab is $288,000, so this is still a huge bargain for the company given the potential returns.